A phase I trial of Proton stereotactic body radiation therapy for liver metastases.

Kang, Joseph I; Sufficool, Daniel C; Hsueh, Chung-Tsen; Wroe, Andrew J; Patyal, Baldev; Reeves, Mark E; Slater, Jerry D; Yang, Gary Y

Kang, Joseph I; Sufficool, Daniel C; Hsueh, Chung-Tsen; Wroe, Andrew J; Patyal, Baldev; Reeves, Mark E; Slater, Jerry D; Yang, Gary Y.

Afiliación

Kang JI; Department of Radiation Oncology Loma Linda University Medical Center, Loma Linda, CA, USA.
Sufficool DC; Department of Radiation Oncology Loma Linda University Medical Center, Loma Linda, CA, USA.
Hsueh CT; Department of Medical Oncology, Loma Linda University Medical Center, Loma Linda, CA, USA.
Wroe AJ; Department of Radiation Oncology Loma Linda University Medical Center, Loma Linda, CA, USA.
Patyal B; Department of Radiation Oncology Loma Linda University Medical Center, Loma Linda, CA, USA.
Reeves ME; Department of Surgical Oncology, Loma Linda University Medical Center, Loma Linda, CA, USA.
Slater JD; Department of Radiation Oncology Loma Linda University Medical Center, Loma Linda, CA, USA.
Yang GY; Department of Radiation Oncology Loma Linda University Medical Center, Loma Linda, CA, USA.

J Gastrointest Oncol ; 10(1): 112-117, 2019 Feb.

Article en En | MEDLINE | ID: mdl-30788166

Palabras clave

Phase I; liver metastases; maximum tolerated dose (MTD); proton therapy; stereotactic body radiation therapy (SBRT)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Gastrointest Oncol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google